TBP-PI-HBr + Imipenem-cilastatin + Dummy Infusion + Dummy Tablets
Phase 3Completed 0 views this week 0 watching💤 Quiet
Interest: 30/100
30
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Urinary Tract Infection
Conditions
Urinary Tract Infection, Acute Pyelonephritis
Trial Timeline
Dec 21, 2023 → Feb 6, 2025
NCT ID
NCT06059846About TBP-PI-HBr + Imipenem-cilastatin + Dummy Infusion + Dummy Tablets
TBP-PI-HBr + Imipenem-cilastatin + Dummy Infusion + Dummy Tablets is a phase 3 stage product being developed by Spero Therapeutics for Urinary Tract Infection. The current trial status is completed. This product is registered under clinical trial identifier NCT06059846. Target conditions include Urinary Tract Infection, Acute Pyelonephritis.
What happened to similar drugs?
20 of 20 similar drugs in Urinary Tract Infection were approved
Approved (20) Terminated (1) Active (0)
Hype Score Breakdown
Clinical
17
Activity
8
Company
5
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT06059846 | Phase 3 | Completed |
Competing Products
20 competing products in Urinary Tract Infection